These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 329813)

  • 1. Effects of drugs upon exercise tests in coronary insuffiency.
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
    Candau LA; Pereira LS; Lavall MA; Carvalho CR
    Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
    [No Abstract]   [Full Text] [Related]  

  • 8. Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise.
    Balasubramanian V; Khanna PK; Naryanan GR; Hoon RS
    Postgrad Med J; 1976 Mar; 52(605):143-7. PubMed ID: 772647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
    Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of oral verapamil and propranolol on exercise-induced myocardial ischemia and energetics in patients with coronary artery disease: single-blind placebo crossover evaluation using radionuclide ventriculography.
    Josephson MA; Hecht HS; Hopkins J; Guerrero J; Singh BN
    Am Heart J; 1982 Jun; 103(6):978-85. PubMed ID: 7044084
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of verapamil on echocardiographic dimensions of the left ventricle in ischemic cardiopathy: comparison with placebo, propranolol and trinitroglycerin].
    Fonzo R; Cherchi A; Bina P; Mercuro G; Lai C; Cioglia G; Sau F
    Boll Soc Ital Cardiol; 1979; 24(6):623-35. PubMed ID: 121796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stress studies of patients with coronary insufficiency receiving a beta blockader with reference to the beta-sympathicolytic blood level behavior].
    Otten H; Gugler R; Bodem G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1735-8. PubMed ID: 347798
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
    Chlebus H
    Bibl Cardiol; 1976; (35):167-71. PubMed ID: 825097
    [No Abstract]   [Full Text] [Related]  

  • 18. Elective response to propranolol or verapamil in ischemia on effort.
    Levantesi D; Marraccini P; Michelassi C; Dalle Vacche M; L'Abbate A
    Can J Cardiol; 1989 Sep; 5(6):299-304. PubMed ID: 2676121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of verapamil on angina threshold during exercise (author's transl)].
    De Ponti C; Ciliberto R; Sozzi G; Foti FA; Rovelli F
    G Ital Cardiol; 1976; 6(7):1238-45. PubMed ID: 795700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol on coronary insufficiency at work test.
    Areskog NH
    Mal Cardiovasc; 1969; 10(1):41-5. PubMed ID: 5378977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.